1Stability and storage
The ongoing stability program for a drug was inadequate.
Inspection Record
Quimica Canada Limited — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
2Other quality system
The written self-inspection procedure was inadequate.
3Other quality system
The written specifications were inadequate.
4Equipment and facility
The maintenance of evidence was inadequate for manufacturing, packaging, labelling, required testing, storage, and/or distribution, including the respective conditions. The handling of standard operating procedures for good manufacturing practices was inadequate.
5Labeling and packaging
The quality agreement outlining the responsibilities for fabricating, packaging or labelling, and/or testing was inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2023-08-21. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
